当前位置:首页 - 行情中心 - 正海生物(300653) - 财务分析 - 现金流量表

正海生物

(300653)

  

流通市值:29.81亿  总市值:29.81亿
流通股本:1.80亿   总股本:1.80亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金87,394,973.57398,607,419.1295,873,119.23197,267,291.74
  收到其他与经营活动有关的现金10,460,872.9443,664,998.3831,519,618.7919,725,994.23
  经营活动现金流入小计97,855,846.51442,272,417.48327,392,738.02216,993,285.97
  购买商品、接受劳务支付的现金5,387,429.2431,187,782.6123,522,796.3315,182,718.2
  支付给职工以及为职工支付的现金20,452,603.4972,894,418.5256,403,911.2838,881,053.86
  支付的各项税费15,117,208.1848,972,645.2937,065,055.4125,557,339.2
  支付其他与经营活动有关的现金44,120,376.19192,026,895.32136,203,944.1889,699,230.49
  经营活动现金流出小计85,077,617.1345,081,741.74253,195,707.2169,320,341.75
  经营活动产生的现金流量净额12,778,229.4197,190,675.7474,197,030.8247,672,944.22
二、投资活动产生的现金流量:
  收回投资收到的现金350,000,0001,010,000,000760,000,000480,000,000
  取得投资收益收到的现金3,948,609.3813,865,484.889,529,308.245,580,551.71
  处置固定资产、无形资产和其他长期资产收回的现金净额160,00066,019.4266,019.42-
  投资活动现金流入小计354,108,609.381,023,931,504.3769,595,327.66485,580,551.71
  购建固定资产、无形资产和其他长期资产支付的现金7,186,000.619,099,705.676,270,913.154,628,107.51
  投资支付的现金370,000,0001,080,000,000800,000,000510,000,000
  投资活动现金流出小计377,186,000.611,089,099,705.67806,270,913.15514,628,107.51
  投资活动产生的现金流量净额-23,077,391.23-65,168,201.37-36,675,585.49-29,047,555.8
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金-81,714,37781,714,37781,714,377
  筹资活动现金流出平衡项目-000
  筹资活动现金流出小计-81,714,37781,714,37781,714,377
  筹资活动产生的现金流量净额平衡项目-000
  筹资活动产生的现金流量净额--81,714,377-81,714,377-81,714,377
五、现金及现金等价物净增加额-10,299,161.82-49,691,902.63-44,192,931.67-63,088,988.58
  加:期初现金及现金等价物余额61,987,525.36111,679,427.99111,679,427.99111,679,427.99
  期末现金及现金等价物余额51,688,363.5461,987,525.3667,486,496.3248,590,439.41
补充资料:
  净利润-82,410,131.7-46,485,732.66
  资产减值准备-266,887.61-252,384.32
  固定资产和投资性房地产折旧-20,167,864.98-10,019,312.16
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-20,167,864.98-10,019,312.16
  无形资产摊销-2,624,866.37-1,320,281.76
  长期待摊费用摊销-15,880.52-15,880.52
  固定资产报废损失-33,378.87-21,068.87
  公允价值变动损失--5,108,162.71--6,826,468.71
  财务费用-11,554.07--
  投资损失--8,436,117.26--151,184.09
  递延所得税--340,261.07-675,365.11
  其中:递延所得税资产减少-1,159,904.19-465,799.93
    递延所得税负债增加--1,500,165.26-209,565.18
  存货的减少-5,633,084.02-5,517,578.33
  经营性应收项目的减少--11,641,291.56--12,987,830.63
  经营性应付项目的增加-11,552,860.2-3,330,823.92
  现金的期末余额-61,987,525.36-48,590,439.41
  减:现金的期初余额-111,679,427.99-111,679,427.99
  现金及现金等价物的净增加额--49,691,902.63--63,088,988.58
公告日期2026-04-182026-03-312025-10-252025-08-05
审计意见(境内)标准无保留意见
TOP↑